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Traditional Chinese medicines (TCMs) have been used in China for more than two
thousand years, and some of them have been confirmed to be effective in cancer
treatment. Protein kinases play critical roles in control of cell growth, proliferation,
migration, survival, and angiogenesis and mediate their biological effects through
their catalytic activity. In recent years, numerous protein kinase inhibitors have been
developed and are being used clinically. Anticancer TCMs represent a large class
of bioactive substances, and some of them display anticancer activity via inhibiting
protein kinases to affect the phosphoinositide 3-kinase, serine/threonine-specific protein
kinases, pechanistic target of rapamycin (PI3K/AKT/mTOR), P38, mitogen-activated
protein kinase (MAPK) and extracellular signal-regulated kinases (ERK) pathways. In
the present article, we comprehensively reviewed several components isolated from
anticancer TCMs that exhibited significantly inhibitory activity toward a range of protein
kinases. These components, which belong to diverse structural classes, are reviewed
herein, based upon the kinases that they inhibit. The prospects and problems in
development of the anticancer TCMs are also discussed.
Keywords: Traditional Chinese Medicine, protein kinase inhibitors, anticancer activity, PI3K/AKT/mTOR, MAPK,
ERK
INTRODUCTION
The protein kinase family encompasses all enzymes in the human body that catalyze the transfer of
a phosphate group from a high energy molecule such as adenine triphosphate (ATP) to a specific
amino acid in a protein. The human genome codes for more than 500 different protein kinases,
which are divided into different families according to their selectivity for substrates (Sharma et al.,
2008). Protein kinases play important roles in regulating cellular functions, including proliferation,
survival, apoptosis, motility as well as metabolism and DNA damage repair, etc. Protein kinases
such as cellular Src (c-Src), c-Abl, mitogen activated protein kinase (MAPK), phosphotidylinositol-
3- kinase (PI3K), serine/threonine -specific protein kinase (AKT) and the epidermal growth factor
receptor (EGFR), are commonly activated in cancer cells and known to play roles in tumorigenesis.
Many of these occur in the same signaling pathway; EGFR kinase family members (HER1 [EGFR],
HER2, HER3, and HER4) transmit signals through MAPK and PI3K to promote cell proliferation
(Goldstein et al., 2008). The central role of kinases in virtually all networks of signal transduction is
the driving motivation useful for the development of compounds modulating their activities (Ferré
et al., 2014).
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In the past decades, numerous natural compounds with
inhibitory effects on protein kinases have been identified or
developed and some of them have been approved by the Federal
Administration Agency (FDA) in the United States and used
successfully in the treatment of human cancers clinically. In
recent years, an increasing number of novel compounds have
been isolated from Traditional Chinese Medicines (TCMs), and
many of them have been reported to possess potent anticancer
activity via inhibition of protein kinase mediated signaling
pathways, including PI3K/AKT/mTOR, P38 MAPK, and ERK
(Figure 1). In this mini-review, we focus on those compounds
isolated from TCMs with inhibitory effects on protein kinases
and present an overview of their anticancer effects and potentials
in pharmaceutics for cancer therapy.
COMPONENTS ISOLATED FROM TCMS
THAT INHIBIT MAPK
MAPK, a serine/threonine specific protein kinase, regulates
a variety of biological processes including cell survival,
proliferation, differentiation, and apoptosis through downstream
signal transduction cascades (Sun et al., 2010). The classical
MAPK family consists of three subfamilies, i.e., the ERKs,
the c-Jun N-terminal kinases (JNKs)/stress-activated protein
FIGURE 1 | Schematic depiction of TCM components that serve as protein kinase inhibitors. The PI3K/AKT/mTOR, P38 MAPK, and ERK pathways are
important players in cell death induced by protein kinases. Many compounds isolated from TCMs are capable of inducing cell death via affecting different protein
kinase pathways.
kinases (SAPKs), and the p38 MAPKs (Chang and Karin, 2001;
Kannan-Thulasiraman et al., 2006). JNKs and p38 MAPKs
play critical roles in the signaling mechanisms that orchestrate
cellular response to various types of cellular stress (Dhanasekaran
and Reddy, 2008; Wagner and Nebreda, 2009). It has been
acknowledged that the ERK signaling pathway is also very
important in carcinogenesis. Selective inhibitors of these kinases
are likely to affect cellular events with high specificities and
are therefore the molecules of significant interest for discovery
and development of anticancer pharmaceuticals (Nakao and
Fusetani, 2007).
Curcuma longa L. is an important herb used in TCM to treat
various types of pain and inflammation. Curcumin (Figure 2),
an apolyphenolic compound, is isolated from the rhizomes of
Curcuma longa L.. Recent studies have shown that curcumin
has anti-tumor effect to inhibit cell proliferation and promote
cell apoptosis in several types of cancer including hepatocellular
carcinoma, lung cancer, breast cancer, colorectal cancer, etc.
(Johnson et al., 2009; Banerjee et al., 2010; Cheng et al., 2010;
Saha et al., 2010). Curcumin significantly activates the JNK
and p38 MAPK, but not the ERK, signaling pathways via
phosphorylation, thus down-regulating anti-apoptotic proteins
Bcl-2, Bcl-XL, Mcl-1, and survivin in human HCT-116 colon
cancer cells during apoptosis process (Collett and Campbell,
2004). Curcumin induces apoptosis of THP-1 human monocytic
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FIGURE 2 | Chemical structures of components isolated from TCMs with inhibitory effects via MAPK pathway.
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leukemia cells by activation of the JNK/ERK signaling pathway
(Yang et al., 2012). Curcumin can also block cell cycle progression
at the G2/M phase and induce apoptosis by regulation of
ERK1/2 phosphorylation in nasopharyngeal carcinoma cells
(Wang et al., 2013). Curcumin halts the growth of human
HepG2 liver xenograft tumors in nude mice. Curcumin down-
regulates the expression of p-ERK1/2 and p-AKT in tumor
tissues by immunohistochemical analyses (Chintana et al.,
2011). Furthermore, curcumin inhibits proliferation of colorectal
carcinoma cells by modulating the Akt/mTOR signaling pathway
(Johnson et al., 2009). Curcumin as an antitumoral agent is
currently under phase II clinical development for prevention
of colorectal cancer. Pharmacokinetic studies show that the
absorbed curcumin conjugates with glucuronic acid and sulfate,
and metabolized to glucuronic acid and sulfate conjugates in the
intestine and liver (Ireson et al., 2002). Excretion of curcumin
glucuronides from intestinal cells occurs predominantly at the
apex and to a lesser extent at the basolateral side, thus limiting
its absorption (Usta et al., 2007). In cancer patients, the serum
concentration peaks at 1–2 h after intake and does not exceed
0.60 µg/mL (0.16 µmol/L) even at a dose of 8 g curcumin per
day for 3 months (Cheng et al., 2001). In a dose-escalation
study, curcumin was not detected in the serum for up to 4 h
after administration of single doses of 0.5–8.0 g curcuminoids,
and only low concentrations between 0.03 and 0.06 µg/mL were
detected after single oral dose of 10 or 12 g (Lao et al., 2006).
The low bioavailability of curcumin is attributed to its limited
absorption, efficient re-secretion from intestinal cells and rapid
intestinal and hepatic conversion to its metabolites dihydro-
, tetrahydro-, and hexahydrocurcumin and their respective
conjugates with glucuronic acid and sulfate, which considerable
hampers its therapeutic efficacy and clinical application (Schiborr
et al., 2010). Recently, the nanoparticle of curcumin was
developed, and the bioavailability of the compound was greatly
improved (Zhang et al., 2014).
Tripterygium wilfordii Hook. f., distributed in Asia, is another
herb used in TCM to treat autoimmune and inflammatory
diseases such as rheumatoid arthritis and tuberculosis. Celastrol
(Figure 2), a triterpenoid isolated from the plant has attracted
great attention due to its potent anticancer effects and its diverse
molecular targets involved in tumorigenesis (Yang H. et al., 2006;
Sethi et al., 2007; Huang et al., 2008; Peng et al., 2010; Kannaiyan
et al., 2011; Lee et al., 2012; Rajendran et al., 2012). The anticancer
mechanisms of the compound include inducing apoptosis in
tumor cells, affecting angiogenesis, regulating the related proteins
of tumor and so on. Recent studies have shown that Reactive
oxygen species (ROS)/c-Jun NH2-terminal kinase (JNK) signal
pathway plays a critical role in celastrol induced cell apoptosis;
treatment of cancer cells with celastrol activates caspase-3, -8, -
9, DR5, and cleavage of PARP, Bid, upregulates the expression
of LC3B-II. The augmentation of JNK phosphorylation and ROS
generation is another important event in celastrol induced cell
apoptosis (Li H. Y. et al., 2015). In addition, celastrol is able
to suppress the expression of vascular endothelial growth factor
receptor (VEGFR), and inhibits the growth of human glioma
xenografts in nude mice (Huang et al., 2008). Additionally,
treatment with celastrol resulted in significant inhibition of the
tumor growth without host toxicity in nudemice bearing prostate
tumors (Yang H. et al., 2006). These studies suggest that celastrol
is a promising candidate for development as an anticancer agent.
A sensitive and precise LC–MS/MS assay was developed to
determine the pharmacokinetic profiles of celastrol in rats (Zhang
et al., 2012). The results showed that oral administration of pure
celastrol leads only to an bioavailability of 17.06%, whereas after
oral administration of TGV tablets, the absolute bioavailability
of celastrol in female rats increased up to 94.19%, demonstrating
improved absorption properties of celastrol (Zhang et al., 2012).
Chelidonium majus L. is used in TCM to treat ulcer and
gastrointestinal pain. Chelerythrine (Figure 2) is a benzene
alkaloid isolated from the herb. Chelerythrine has been proved
to possess potent antitumor effect on various cancers, in
particular breast, colon and prostate cancers (Chmura et al.,
2000). The mechanism of action of chelerythrine involves several
pathways, including cell cycle arrest andinhibition of protein
synthesis. Chelerythrine activated JNK/p38 MAPK pathways in
a concentration and time-dependent manners in Hela cervical
cancer cells (Yu et al., 2000). Treatment of chelerythrine resulted
in activation of MEK/ERK1/2 signaling pathway, up-regulation
of downstream kinases (p90RSK), and finally induction of
apoptosis in human osteosarcoma cells (Yang et al., 2008).
Chelerythrine can also induce G1 phase arrest and bimodal cell
death in human leukemia HL-60 cells (Vrba et al., 2008). In
addition, chelerythrine is a specific inhibitor of protein kinase C
(PKC), blocking PKC translocation from cytosol to membrane,
contributed to the progression of apoptotic tumor cell death
(Siomboing et al., 2001). Recent study also demonstrated that
chelerythrine possesses the activity of inhibiting the telomerase
activity and promoting cancer cell death via binding with human
telomeric DNA to form the four-stranded G-quadruplex (Yang
et al., 2011).
Emodin (Figure 2) is an active ingredient derived from the
rhizome of Rheum palmatum L., which is widely used in TCM
as a laxative over thousands years (Ma and Li, 2014; Qu et al.,
2015). In the last decades, increased attention is focused on
the anticancer activities of emodin since studies have shown
that the compound exhibited the effects of antiproliferation and
apoptosis-induction in a number of human cancers such as
colon, cervical and gastric cancer (Yaoxian et al., 2013; Xie et al.,
2014). Emodin inhibited proliferation and induced apoptosis of
hepatocellular carcinoma cells both in vitro and in vivo through
MAPK and PI3K/AKT signaling pathways in a dose-dependent
manner (Lin et al., 2016). Emodin signifcantly activates the
phosphorylation of ERK and p38, which associated with
apoptosis of hepatocellular carcinoma (HCC) cells. Moreover,
emodin can induce apoptosis of colorectal cancer cells through
activating p53/p38/Puma pathway by triggering ROS production
(Liu et al., 2015). Pharmacokinetic study revealed that emodin
was predominantly found in liver and brain after oral intake of
Polygonum cuspidatum, which is a widely used in TCM (Lin et al.,
2012). After intragastric administration at doses of 20 and 40
mg/kg, emodin rapidly underwent phase II metabolism to form
its glucuronide derivative, and the parent form of emodin was
almost undetectable in vivo (Shia et al., 2010). Glucuronidation
metabolism appeared to be one of the main reasons for the very
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poor oral bioavailability of emodin as found in a cultured Caco-2
cell model (Liu et al., 2012).
Bolbostemma paniculatum (Maxim.) Franquet is used in
TCM to treat swollen skin, tuberculosis and abscess of the
lung. Tubeimoside-1 (Figure 2) as a novel compound with
potent anticancer activity is isolated from the plant (Yin et al.,
2011; Yu et al., 2001). Tubeimoside-1 inhibited the growth of
several cancer cells including gliomas, lung cancer and liver
cancer (Zhang et al., 2011; Wang et al., 2011a; Jia et al.,
2015). Tubeimoside-1 induced phosphorylation of apoptosis
signal-regulating kinase 1 (ASK-1) and its downstream target
proteins JNK and p38 in a dose-dependent manner, leading
to mitochondrial apoptosis in DU145 human prostate cancer
cells (Yang et al., 2016). Activation of MAPK-JNK signaling
pathway plays an important role in tubeimoside-1 induced cell
cycle arrest in lung cancer cells (Hao et al., 2015). Tubeimoside-
1 can also sensitize cell response to cisplatin in cisplatin-
resistant human ovarian cancer cells (A2780/DDP) through
down-regulation of ERK and up-regulation of p38 (Liu H. Z.
et al., 2011). Tubeimoside-1 increased the expression of CHOP
and phosphorylated p38, resulting in G2/M phase arrest and
apoptosis in SKOV-3 human ovarian carcinoma cells (Chen W.
J. et al., 2012). In addition, tubeimoside-1 can induce oxidative
stress-mediated apoptosis and G2/M phase arrest in HepG2 liver
cancer cells via NF-κB, JNK, and p53 pathways (Yin et al., 2011).
LC/MS analysis was performed to check the pharmacokinetics of
tubeimoside-1 after intravenous and oral administration in rats
(Liang et al., 2007). Tubeimoside-1 was found with very slow
clearance via hepatic tissues. The absolute oral bioavailability of
tubeimoside-1 was only 0.23%, suggesting that tubeimoside-1 has
poor absorption or undergoes acid-induced degradation.
Atractylodes lancea rhizome is recognized to possess the
diuretic and stomachic effects in TCM, and used to treat
abdominal distention and dismembered sores in China. Two
oil products, β-eudesmol (Figure 2) and hinesol (Figure 2) are
isolated from the plant. Recent study showed that β-eudesmol
is able to activate JNK/MAPK signaling pathway, and induce
cell death through mitochondria-mediated intrinsic apoptosis
modulated by JNK-dependent downregulation of Bcl-2 in HL60
leukemiacells (Li Y. et al., 2013). β-eudesmol induced the
decrease of matrix metalloproteinases (MMP) and the release
of cytochrome C from mitochondria in HL60 leukemia cells
accompanied with the activation of caspase-9, caspase-3, and
cleavage of PARP. β-eudesmol exhibited the inhibitory effect on
the growth of various cancer cells including HeLa cervical cancer,
SGC-7901 gastric cancer, and liver cancer BEL-7402 cells in vitro
(Tsuneki et al., 2005). Hinesol, a sesquiterpenoid component
isolated from the herb, also induced apoptosis via JNK signaling
pathway. Hinesol treatment significantly activated JNK and ERK,
but did not alter the activation of p38; thus hinesol may represent
a novel anticancer agent in the treatment of leukemia (Masuda
et al., 2015).
Bidens bipinnata L. has been used in TCM as a basic
drug historically in the local area of Guangxi, China, to treat
many kinds of diseases such as malaria, diarrhea, dysentery,
hepatitis, acute nephritis, hypertension, hyperlipidaemia, and
diabetes. Isoquercitrin (Figure 2) is a favonoid compound
with anticancer activity isolated from Bidens bipinnata L
(Yang et al., 2013; Wu et al., 2013a). Isoquercitrin strongly
inhibited the phosphorylation of ERK and p38MAPK
proteins while promoting the phosphorylation of JNK, thus
inducing apoptosis in HepG2 liver cancer cells in a caspase
-dependent manner (Huang et al., 2014). Isoquercitrin
can also block the liver cancer cells at the G1 phase and
exhibited inhibitory effect on transplanted tumor growth in vivo
(Huang et al., 2014).
The roots of Echinops grijsii, is believed to possess the
effects of antiinflammation, detoxicating, and expelling miasma
in TCM, and used to relieve the distention of the breast and
stimulating milk secretion (Jin et al., 2008; Zhang et al., 2008).
A thiophene derivative, 2-(Pro-1-ynyl)-5- (5,6-dihydroxypenta-
1,3-diynyl) thiophene (PYDDT) (Figure 2) is isolated from
the herb. PYDDT induces the production of ROS, and the
activation of JNK but not p38 and ERK1/2, leading to induction
of mitochondrial-mediated apoptosis in human colon cancer
SW620 cells (Xu et al., 2015). PYDDT-induced apoptosis was
characterized by the cleavage of PARP, activation of caspase 9
and caspase 3, release of cytochrome C from mitochondria, loss
of mitochondrial membrane potential, down-regulation of Bcl-2,
and mitochondrial translocation of Bax.
Fagopyrum tataricum (L.) Gaertn (tartary buckwheat) has
been widely used as an important folk medicine in China as a
nutritional food. Studies have shown that the herb has multiple
benefits including antioxidant, antitumor, antihypotensive,
hypoglycemic, and hypolipidaemic effects (Lin et al., 2011; Karki
et al., 2013). Tatariside G (Figure 2), a novel phenylpropanoid
glycosides compound, was isolated from the roots of Fagopyrum
tataricum (L.) Gaertn. Recent study revealed that tatariside G
notably inhibited cell viability and induced apoptosis in human
cervical cancer HeLa cells through both activation of p38/JNK
phosphorylation and inhibition of Akt phosphorylation (Li et al.,
2014). Tatariside G could elevate the cleaved protein expression
of caspase-3 and caspase-9 in a dose-dependent manner, and
decreased mitochondrial membranep potential (MMP) in HeLa
cells (Li et al., 2014).
COMPONENTS ISOLATED FROM TCMS
TARGETING THE PHOSPHOINOSITIDE
KINASE (PI3K)/SERINE/THREONINE-
SPECIFIC PROTEIN KINASE (AKT)
The PI3K signaling pathway contributes to tumor development
and progression in many types of human malignancies. It is well
acknowledged that activation of AKT, the major downstream
effecter of PI3K, is frequently observed in human tumors
(Brugge et al., 2007; Yu et al., 2012), and the activation
of AKT promotes the development of cancer as well as
resistance to chemotherapy and radiation therapy. Additionally,
immunohistochemical analysis has shown that AKT activation
is a poor prognostic factor in various cancers (LoPiccolo et al.,
2007). Therefore, PI3K/AKT signaling pathway is an attractive
target for cancer therapy (Hennessy et al., 2005; Crowell et al.,
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2007). Several components isolated from TCMs were found to
induce cell death via inhibiting PI3K/AKT pathway.
Alkannin (Figure 3) is the major active ingredient isolated
from Arnebia euchroma roots, which has long been used as anti-
inflammation and anti-tumor herb in Chinese folk medicine
(Feng et al., 2003). Studies have shown that alkannin exerted
antitumor effects by inhibiting cancer cell proliferation and
inducing apoptosis via inhibiting DNA topo-isomerase I/II
activity, anti-telomerase activity and anti-angiogenesis (Lu et al.,
2002; Yang F. et al., 2006; Lim et al., 2007). SYUNZ-16,
a synthesized alkannin derivative, is one of the compounds
with potent antitumor activities (Wang et al., 2006; Xie et al.,
2006a,b, 2007). SYUNZ-16 displayed potent cytotoxicity in
diversified cancer cell lines including nasopharyngeal carcinoma,
hepatocellular cancer, leukemia, cervical cancer, gastric cancer
and breast cancer. SYUNZ-16 inhibits AKT signaling pathway,
and down-regulates the phosphorylation of AKT in a dose and
time-dependent manner, subsequently initiating apoptotic events
in Hep3B liver cancer and GLC-82 lung cancer cells (Deng et al.,
2010). SYUNZ-16 can obviously inhibit the proliferation of these
cancer cells via induction of apoptosis with the activation of
caspase -3 and PARP cleavage (Deng et al., 2010). SYUNZ-16 can
also partially attenuate the phosphorylation levels of forkhead
transcription factors (FKHR and FKHRL1), which are important
substrates of AKT (Tokunaga et al., 2008). SYUNZ-16 exhibits
inhibitory effects on murine S-180 sarcoma allografts and GLC-
82 lung cancer xenografts in vivo (Deng et al., 2010).
Toad venom (venenum bufonis, also called Chan’su) is
derived from the dried skin secretions of giant toads (Bufo
gargarizans Cantor or Bufo melanostictus Suhneider) and has
been widely used alone or in combination with other herbal
ingredients for cancer treatment over centuries in China.
An injectable formulation of toad venom called cinobufacin
(Huchansu) was developed to treat various solid tumors in
China in 1990’s. Clinical studies have shown that cinobufacin
significantly increased the antitumor efficacy of docetaxol or
cisplatin in the combination therapy. Decreased toxicity and
improved life quality were also observed in the clinical trial with
cancer patients (Gong et al., 2010). Arenobufagin (Figure 3),
one of the components of toad venom, was reported to have a
broad spectrum of antitumor activity in cancer cells, including
MCF-7, MCF-7/ADR, HepG2, and some other carcinoma cell
lines (Zhang et al., 1992; Masuda et al., 1995; Yu et al.,
2010). PI3K/AKT signaling pathway plays a central role in
arenobufagin-mediated cell death. Arenobufagin can inhibit
AKT with involvement of Phosphatase and tensin homolog
(PTEN) activation as well as PDK1 and PI3K inhibition, and
induces apoptosis in HCC cells. Arenobufagin treatment leads
to marked decrease in the expression of mTOR. Inhibition
of PI3K/AKT/mTOR pathway can promote the development
of both autophagy and apoptosis induced by arenobufagin
(Brown et al., 2003; Teachey et al., 2006; Chen G. et al.,
2012). Arenobufagin induces mitochondria-mediated apoptosis
in HepG2 and HepG2/ADM cells, accompanied with a decrease
of mitochondrial potential, and an increase of Bax/Bcl-2
expression ratio. Activation of caspase-3 and caspase-9 as well as
cleavage of PARP was also found in arenobufagin induced cell
apoptosis (Zhang D. M. et al., 2013). In addition, arenobufagin
is able to block VEGF-mediated angiogenesis (Li M. et al., 2013).
Therefore, arenobufagin as the main active ingredients of toad
venom has the potential to be developed as a novel anticancer
agent (Liu et al., 2009; Hu et al., 2011). The pharmacokinetic
characteristics of arenobufagin has been studied in six Sprague-
Dawley rats by ultra-fast liquid chromatography–tandem mass
spectrometry (Li G. et al., 2013). Arenobufagin can be detected
in plasma within 5 min to a peak concentration of 1.98 ng /mL
after intraperitoneal administration 4.0 mg/kg, which indicates
that arenobufagin can be absorbed quickly (Li G. et al., 2013).
Radix Stephaniae tetrandrae is used to treat the syndrome
of dampness-heat related diseases in TCM over thousands of
years and it is widely used to treat cystitis, prostatitis, urethritis,
pyelonephritis, vaginitis as well as rheumatism in China. A
bisbenzylisoquinoline alkaloid, tetrandrine (Figure 3) is isolated
from the roots of Radix Stephaniae tetrandrae (Bosch et al.,
2004; Liu et al., 2006). Studies have shown that tetrandrine is
able to inhibit cell proliferation and induces apoptosis of cancer
cells (Yan et al., 2006; Chen et al., 2008). ERK and PI3K-AKT
signaling pathways play a critical role in tetrandrine induced
cell apoptosis (Lin et al., 2008). Treatment of cancer cells with
tetrandrine leads to the suppression of AKT activation, which in
turn regulated the function of Bcl-2 family proteins and activated
caspase cascades (Liu C. Y. et al., 2011). Tetrandrine also
has the potential of immunomodulation and anti-inflammatory
activity, which plays a positive role in HCC therapy (Shen et al.,
2001). Based on a long history of clinical application in TCM,
tetrandrine is considered to be a safe agent, and may be an
attractive candidate compound for liver cancer therapy. The
Pharmacokinetic properties of tetrandrine were studied with a
simple HPLC method in rabbits. The concentration-time data of
tetrandrine fitted the classical two-compartment model, whether
the drug was administered intravenously or orally (Jiang et al.,
2011). The ratio of tetrandrine AUC (10 mg/kg by gavage) to
AUC (5mg/kg by intravenous injection) was about 30% and ratio
of their Cmax was less than 20%, suggesting that tetrandrine is
less absorbed from digestive tract or has a strong first pass effect
as the gavage dose is double that of intravenous dose (Jiang et al.,
2011).
Rhizoma zedoariae possesses the effects of subsiding swelling,
relieving pain in TCM and used to tread rheumatalgia,
headache and chestpain. Elemene (1-methyl-1- vin- yl-2,4-
diiso- propenyl-cyclohex-ane, Figure 3), a noval lipid-soluble
component, is extracted from the rhizoma of zedoariae (Li
et al., 2009). β-Elemene, the most active component of elemene,
has been shown to be effective against various cancers in
vitro and in vivo, such as lung cancer, colorectal cancer and
glioblastoma (Wang et al., 2005; Yao et al., 2008; Li et al.,
2009; Xie et al., 2009). Recently, β-Elemene has been approved
by the State Food and Drug Administration of China for
the treatment of some solid tumors (Tan et al., 2000). β-
Elemene induces apoptosis and autophagy through inhibition
of the PI3K/Akt/ mTOR/p70S6K1 signaling pathway in human
gastric cancer cells (Liu J. et al., 2011). Following treatment
with β-Elemene, the level of phospho-AKT was obviously
downregulated, leading to the down-regulation of downstream
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FIGURE 3 | Chemical structures of components isolated from TCMs with inhibitory effects on PI3K/AKT pathway.
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phosphor-mTOR as well as phospho- p70S6K1. The cleavage
of PARP and conversion of LC3 I to LC3 II is consistent with
the change of PI3K/Akt/mTOR/p70S6K1 activity. β-Elemen can
induce G2/M phase arrest and apoptotic cell death in non-
small lung cancer cells with activation of caspases -9, -3, and
7 (Wang et al., 2005). β-Elemen promotes apoptosis through
inhibiting the expression of Bcl-2 and survivin in MCF-7 human
breast cancer cells (Hu et al., 2004). In addition, β-Elemen can
suppress the expressions of VEGF, basic fibroblast growth factor
(bFGF), and epidermal growth factor (EGF), and exhibit anti-
cancer ability on laryngeal cancer cells both in vitro and in vivo
(Tao et al., 2005, 2006). β-Elemenal was a primary metabolite in
bile of rat after β-Elemen intravenous administration. A sensitive
gas chromatographic–mass spectrometric assay was developed
to determine the level of β-Elemen and β-Elemenal in human
plasma (Chen et al., 2009). The peak plasma concentration
(Cmax) and area under curve (AUC) of β-Elemen were prone to
increase in proportion to the dose, but there were no significant
differences among Cl values in the range of dosages. Moreover,
no β-Elemenal was detected in plasma, and there was no other
obvious homologous fragment elsewhere, which indicated that β-
Elemen may be mainly decomposed into some small hydrophilic
metabolites. Further investigations are needed to determine the
biological process of β-Elemen in vivo (Chen et al., 2009).
Pogostemon Cablin (Blanco) Benth, commonly known as
“Guang-huoxiang” in China, is a TCM herb widely used to treat
gastrointestinal diseases in many Asian countries (Chen et al.,
2015). Pogostone (Figure 3) is one of the major constituent
of Pogostemon cablin, and possesses various bioactivities, such
as anti-fungal (Li et al., 2012), anti-bacterial (Peng et al.,
2014), pesticidal (Huang et al., 2013), and anti-inflammatory
activities (Su et al., 2015). Recent studies have revealed that
pogostone exhibited potent anti-proliferative activities against
multiple human cancer cell lines, especially on human colorectal
cancer cells HCT116 (IC50: 18.7 ± 1.93 µg/mL; Cao et al.,
2016). Pogostone significantly inhibited AKT and mTOR
phosphorylation in a dose-dependent manner, which contributed
to the initiation of autophagy and apoptosis in HCT116 cells
(Cao et al., 2016). After treatment of pogostone, a dose-
dependent increase in the levels of LC3 -II, cleaved caspase-
3 and caspase-7, and a significant decrease in pro-caspase-3
levels were observed in HCT116 cells. Pogostone also inhibited
the growth of HCT116 tumor, and reduced the tumor volume
significantly with well tolerated by the host in vivo. Pogostone
may be developed as a promising drug in the treatment of human
colorectal cancer. The preclinical pharmacokinetic investigation
of pogostone has been performed in rats after intravenous
and oral administration (Chen H. et al., 2013). The results
showed that the blood concentration of pogostone appeared to
increase nonproportionally between 5 and 20 mg/kg under the
intravenous route (Chen H. et al., 2013).
Stellera chamaejasme L. is used to treat skin ulcer and
abdominal distension in TCM. Chamaejasmine (Figure 3), a
flavone compound isolated from Stellera chamaejasme L, displays
potent cytotoxicity in multiple cancer cell lines, including human
lung cancer A549 cells, and human breast cancer MDA-MB-
231 cells (Yu et al., 2011; Zhang T. et al., 2013; Yang et al.,
2015). Recent study showed that chamaejasmine could induce
apoptosis in HeLa cervical cancer cells, mediated through
PI3K/Akt signaling cascades (Qiang and Li, 2017). Treatment of
chamaejasmine inactivates AKT to trigger apoptosis in human
hep-2 larynx carcinoma cells (Wang et al., 2011b).
Polygonum cuspidatum is believed to possess the effects
of dissipating blood stasis and pain relief. Resveratrol 3,4,5-
trihydroxystilbene, (Figure 3), a polyphenol compound, is
isolated and extracted from P. cuspidatum with broad bioactivity
including anti-bacterial, anti-inflammatory, anticancer, anti-
hyperlipidemia anti-lipid peroxidation and pro-apoptotic effects
(Piotrowska et al., 2012; Kucinska et al., 2014). Resveratrol
inhibited PI3K and Akt phosphorylations, and subsequently
triggered the dephosphorylation of glycogen synthase kinase 3
beta (GSK3β), which resulted in cyclin D1 degradation and
eventually cell cycle arrest and apoptosis in MGC803 human
gastric cancer cells (Jing et al., 2016). Furthermore, resveratrol
can inhibit the invasion and metastasis of colorectal cancer cells
through metastasis associated lung adenocarcinoma transcript
1 (MALAT1) mediated Wnt/β-catenin signal pathway (Ji et al.,
2013). However, the water solubility of resveratrol was very poor
with approximately 0.03 mg/mL (Vian et al., 2005). In vivo
pharmacokinetic study confirmed that the oral bioavailability
of resveratrol approaches zero, although administrated with
relatively high concentrations of the compounds (Wenzel and
Somoza, 2005). Therefore, it is important to enhance the
bioavailability of resveratrol, which is considered as the main
challenge in successfully applying resveratrol in clinical and
health-promoting interventions (Chang et al., 2016).
Ophiopogonin B (OP-B, Figure 3) is a bioactive component
of Radix Ophiopogon Japonicus, which is often used in TCM to
treat pulmonary disease (Wang Y. H. et al., 2011). OP-B can
significantly decrease cell viability in a panel of NSCLC cell lines.
OP-B inhibited the PI3K/Akt/mTOR/p70S6K signaling pathway,
suppressed p-AKT at both Ser308 and Thr473 and induced
autophagy in NCI-H157 and H460 human lung cancer cells
(Chen M. et al., 2013). As a prospective inhibitor of AKT/mTOR,
OP-B can also exhibit autophagy-dependent antitumor effects
via repression AKT/mTOR signaling pathway in human cervical
cancer HeLa cells (Xu et al., 2013). OP-B can induce autophagy
and apoptosis in A549 human lung cancer cells both in vitro
and in vivo (Chen et al., 2016). Moreover, OP-B significantly
decreases cell proliferation and induces apoptosis in SGC-7901
human gastric cancer cells via triggering the JNK1/2 and ERK1/2
signaling pathways (Zhang et al., 2016).
COMPONENTS ISOLATED FROM TCMS
THAT TARGET EPIDERMAL GROWTH
FACTOR RECEPTOR (EGFR)
EGFR (also known as erbB1 or HER1) belongs to the family of
tyrosine kinase receptors that include erbB2 (Neu, HER2), erbB3
(HER3), and erbB4 (HER4). EGFR once combined with EGF
can promote the related genes in the cell nucleus, leading to cell
proliferation. EGFR is commonly highly expressed in a variety of
malignant tumors (Nakao and Fusetani, 2007), and the abnormal
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activation of EGFR is closely correlated with tumor cell biology,
acting as an indicator of poor prognosis for the patients with
cancer.
The root of Panax ginseng C. A. Mey (Gingsheng) is believed
to possess the activity of nourishing vitality and is widely used
in China for patients with poor health condition. Ginsenoside
Rg3 (GS-Rg3, Figure 4) is one of the active ingredients in
Ginsheng with significant antitumor activity. It is also the main
component of Shenyi capsule, the first drug used for controlling
the metastasis and recurrence of cancer patients in China. GS-
Rg3 shows antitumor effects in a variety of cancers such as
gastric, lung, colon, breast, and liver cancers etc. (Lu et al., 2008;
He et al., 2011). GS-Rg3 displays various anticancer activities
including inhibiting tumor growth, invasion and metastasis,
and suppressing angiogenesis in tumor tissues and improving
immunity. Synergistic anticancer effects are found when it
combined with chemotherapeutic agents (Keum et al., 2003).
GS-Rg3 inhibited epithelial-mesenchymal transition (EMT) and
invasion of lung cancer by down-regulating fucosyltransferase 4
(FUT4) mediated EGFR inactivation and blocking MAPK and
NF-κB signal pathways (Shan et al., 2015; Tian et al., 2016). GS-
Rg3 reduced the expressions of EGFR and pEGFR in MCF-7
breast cancer cells in a dose-dependent manner, suggesting that
GS-Rg3 inhibits the tumor growth by targeting EGFR and its
down- stream signal transduction pathways (Wang et al., 2008).
GS-Rg3 is also an inhibitor of VEGF and bFGF; significantly
decreasing the expression of these angiogenesis factors in human
A549 lung cancer and human umbilical vein endothelial cells
(HUVEC) (Chen et al., 2005). In vitro as well as in vivo study
have been carried out to determine the blood level of GS-Rg3
in rat plasma and its major metabolites using an HPLC/Q/TOF
analytical approach. GS-Rg3 has an average half-life of 18.5 min
after intravenous administration dosed at 5 mg/kg, whereas it
was not detected in rat plasma after oral administration at 100
mg/kg (Qian et al., 2005). GS-Rg3 wasmetabolized to ginsenoside
Rh2 and protopanaxadiols (PPD) when anaerobically incubated
with human fecal microflora, and the deglycosylated metabolites
display activities comparable to or higher than that of GS-
Rg3 (Xie et al., 2005). However, GS-Rg3 has poor solubility
and oral bioavailability, which limits its clinical application.
Recently, a derivative of the compound, 20(S)-ginsenoside Rg3,
was designed and developed as a new drug. Pharmacokinetics has
been studied in healthy volunteers in China (Zhao et al., 2016).
20(S)-ginsenoside Rg3 was generally well tolerated, and exhibited
a pharmacokinetic profile suitable for once-every-2-days dosing
regimen (Zhao et al., 2016).
Epimedium koreanum Nakai is believed to possess the
effects of nourishing Yin and strengthening Yang, promoting
blood circulation. Icariside II (Figure 4), a flavonoidglycoside
compound, is isolated from the stems and leaves of epimedium
koreanum Nakai (Aramwit and Wirotsaengthong, 2012). Studies
have shown that icariside II exhibited potent cytotoxicity against
a broad spectrum of human cancer cells through various
pathways (Kang et al., 2012; Wu et al., 2012). Icariside II displays
significant antitumor activity against A431 human epidermoid
carcinoma cells in vitro and in mice bearing osteosarcoma
sarcoma-180 in vivo by suppressing the phosphorylation of
EGFR, down-regulating EGFR downstream signal PI3K/AKT
and Raf/MEK/ERK as well as mTOR pathways in these cancer
cells (Wu et al., 2013b; Geng et al., 2014). Icariside II metabolites
in rats were analyzed using an ultra-performance liquid
chromategraphy/quadrupole- time-of-flight mass spectrometry
method. The results showed that the metabolized mainly via
desugarisation, dehydrogenation, hydrogenation, hydroxylation,
demethylation, glucuronidation, dehydration, and glycosylation
pathways in vivo. Specific hydrolysis of 7-O glucoside in the
gut lumen and glucuronic acid conjugation in the liver was
considered as the main physiologic processes of icariside II (Sun
et al., 2014).
The root of Platycodon grandiflorum (Companulaceae) has
been extensively used to treat several types of chronic
inflammatory diseases in TCM (Shin et al., 2002). Platycodin
D (PD, Figure 4), one of the major saponin components
contained in the herb is reported to display antitumor effect on
several cancer cell lines (Chun et al., 2013). EGFR/PI3K/AKT
pathway plays a critical role in PD induced cell apoptosis and
PD downregulates the expression of EGFR in MDA-MB-231
breast cancer cells subsequently leading to the inhibition of
the PI3K/AKT and MAPK pathways (Chun and Kim, 2013).
Additionally, PD could induce apoptosis and trigger ERK- and
JNK-mediated autophagy in human hepatocellular carcinoma
BEL-7402 cells (Li T. et al., 2015).
The seed of Myristica fragrans Houtt (Nutmeg) is used to
treat diarrhea and ep-igastric pain in TCM. Recent study showed
that one of the components myrislignan (Figure 4) isolated from
nutmeg, displayed potent anticancer activity against A549 lung
cancer cells both in vitro and in vivo (Lu et al., 2016). The effects
of myrislignan on apoptosis and cell proliferation are mediated
by activation of MAPK and inhibition of EGFR signal pathway.
Peganum harmala L. is used to treat cancer in TCMs and
Uygur medicine. A novel compound called 3α-acetoxy-27-
hydroxyolean-12-en-28-oic acid methyl ester (OA, Figure 4) was
isolated from the herb (Wang et al., 2016). OA possesses potent
anticancer activity against NSCLC via inhibiting the activation
of EGFR and its downstream signals. Guo et al. developed a
model to identify the ERBB3 inhibitors from natural products
and TCMs. Several compounds with anticancer activity were
identified; among them, VS1 (Figure 4) is the most promising
component with IC50 value of 269 µM against A549 lung cancer
cells (Guo et al., 2016).
CONCLUSIONS
The discussed components here are isolated from TCMs and
their modes of actions are summarized in Table 1. However, it
should be kept in mind that numerous components from TCMs
display antitumor activity via multiple targets. Most components
discussed above show pro-apoptotic activity mediated by
activation of caspases and downregulation of mitochondrial
antiapoptotic proteins.
In recent years, TCM has gained increasing acceptance and
attention worldwide, and is recognized as a rich source for drug
discovery and development. TCM is widely used in China to
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FIGURE 4 | Chemical structures of components isolated from TCM that target Epidermal Growth Factor Receptor (EGFR).
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TABLE 1 | A summary of Traditional Chinese Medicines as kinase inhibitors.
Name of Anti–tumor
TCMs
Sources Classification Kinase inhibitors and cell lines References
Curcuma Curcuma longa L. Polyphenols JNK/p38 MAPK/ERK HCT-116, THP-1,
CNE1, CNE2, and HepG2 cells
Collett and Campbell,
2004; Chintana et al.,
2011; Yang et al., 2012;
Wang et al., 2013
Celastrol Tripterygium wilfordii Hook. f. Triterpene JNK HOS, MG-63, U-2OS, and Saos-2
cells
Li H. Y. et al., 2015
Chelerythrine Chelidonium majus L. Benzophen anthridine
alkaloid
JNK/p38 MAPK/ERK Hela, HOS, and
U-2OS cells
Yu et al., 2000; Yang
et al., 2008
Emodin Rheum palmatum L. Anthraquinone ERK/p38 MAPK SMMC-7721, SW480,
and SW620 cells
Liu et al., 2015; Lin et al.,
2016
Tubeimoside-1 Bolbostemma paniculatum
Franquet
Triterpenoid saponin JNK/p38 MAPK/ERK DU145, A549, PC9
A2780/DDP, SKOV-3. and HepG2 cells
Liu H. Z. et al., 2011; Yin
et al., 2011; Chen W. J.
et al., 2012; Hao et al.,
2015; Yang et al., 2016
β-eudesmol Atractylodes lancea rhizome Sesquiterpenol JNK HL60 cell Li Y. et al., 2013
Hinesol Atractylodes lancea rhizome Sesquiterpenol JNK/ERK HL60 cell Masuda et al., 2015
Isoquercitrin Bidens bipinnata L. Favonoid JNK/p38 MAPK/ERK HepG2 cell Huang et al., 2014
PYDDT Echinops grijsii Alkynol group-
substituted thiophene
JNK SW620 cell Xu et al., 2015
Tatariside G Fagopyrum tataricum (L.) Gaertn Phenylpropan- oid
glycosides
JNK/p38 MAPK HeLa cell Li et al., 2014
SYUNZ-16 Arnebia euchroma roots b,b-
dimethylacrylalkannin
AKT Hep3B and GLC-82 cells Deng et al., 2010
Arenobufagin Bufo gargarizans Cantor or Bufo
melanostictus Suhneider
C24 steroids PI3K/Akt/mTOR HepG2 and HepG2/
ADM cells
Zhang D. M. et al., 2013
Tetrandrine Radix Stephaniae tetrandrae Bisbenzylisoquinoline
alkaloid
ERK and PI3K/AKT HT-29, Huh7, HepG2
and BEL7402 cells
Chen et al., 2008; Liu C.
Y. et al., 2011
β-Elemene Rhizomazedo- ariae Terpene PI3K/Akt/mTOR MGC803 and SGC7-
901cells
Liu C. Y. et al., 2011; Liu
J. et al., 2011
Pogostone Pogostemon Cablin (Blanco)
Benth
Ketone PI3K/Akt/mTOR HCT116 cell Cao et al., 2016
Chamaejasmine Stellera chamaejasme L. Flavonoid PI3K/Akt HeLa and HEp-2 cells. Wang et al., 2011b; Qiang
and Li, 2017
Resveratrol Polygonum cuspidatum Polyphenol PI3K/Akt MGC803 cell Jing et al., 2016
Ophiopogonin-B Radix Ophiopogon Japonicus Saponin PI3K/Akt/mTOR NCI-H157, H460 and
HeLa cells
Chen M. et al., 2013; Xu
et al., 2013
Ginsenoside Rg3 Ginsheng Saponin EGFR and VEGF A549, H1299, H358,
MCF-7 and HUVEC304 cells
Chen et al., 2005; Wang
et al., 2008; Tian et al.,
2016
Icariside II Yin Yanghuo Horny Goat Weed Flavonoid EGFR A431 cell Wu et al., 2013b; Geng
et al., 2014
Platycodin D Platycodon grandiflorum Saponin EGFR MDA-MB-231 cell Chun and Kim, 2013
Myrislignan Myristica fragrans Houtt Lignans EGFR A549 cell Lu et al., 2016
OA Peganum harmala L. Triterpene EGFR A549 cell Wang et al., 2016
VS1 Heterocycle ERBB3 A549 cell Guo et al., 2016
reduce the side effects of chemotherapeutic drugs and improve
the outcome of conventional treatment. It should emphasize
that in some cases, the mixed extracts of TCM display more
potent antitumor effects than the single individual component
and exhibited synergistic effects with most TCM preparation.
Our recent study revealed that the crude extract of clove bud
can induce cell death via apoptotic pathway and inhibit the
growth of cancer cells both in vitro and in vivo. However, the
isolated bioactive component, Oleanolic acid, displays much
weaker antitumor activity compared to the crude extract in the
nude mouse models of xenografted human tumors, suggesting
synergistic antitumor effects exist among the components in the
extract of clove bud (Liu et al., 2014).
Although, chemotherapy is acknowledged as one of the
most effective therapeutic methods for cancers in late stage,
it faces serious side effects and drug resistance. TCM provide
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a novel strategy for cancer therapy. However, the underlying
mechanisms of most TCM have not been elucidated yet.
On the other hands, numerous components isolated from
TCMs possess poor bioavailability; novel approaches, including
chemical modification, nanotechnology etc. should be employed
to improve their efficacy in vivo. It is likely that the efficacy of
TCM in cancer treatment may lead to novel strategies in fight
against various cancers.
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